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ABSTRACT Nystatin is a membrane-active polyene antibiotic that is thought to kill fungal cells by forming ion-permeable
channels. In this report we have investigated nystatin interaction with phosphatidylcholine liposomes of different sizes (large
and small unilamellar vesicles) by time-resolved ﬂuorescence measurements. Our data show that the ﬂuorescence emission
decay kinetics of the antibiotic interacting with gel-phase 1,2-dipalmitoyl-sn-glycero-3-phosphocholine vesicles is controlled by
the mean number of membrane-bound antibiotic molecules per liposome, hAi. The transition from a monomeric to an oligomeric
state of the antibiotic, which is associated with a sharp increase in nystatin mean ﬂuorescence lifetime from ;7–10 to 35 ns,
begins to occur at a critical concentration of 10 nystatin molecules per lipid vesicle. To gain further information about the
transverse location (degree of penetration) of the membrane-bound antibiotic molecules, the spin-labeled fatty acids (5- and 16-
doxyl stearic acids) were used in depth-dependent ﬂuorescence quenching experiments. The results obtained show that
monomeric nystatin is anchored at the phospholipid/water interface and suggest that nystatin oligomerization is accompanied
by its insertion into the membrane. Globally, the experimental data was quantitatively described by a cooperative partition model
which assumes that monomeric nystatin molecules partition into the lipid bilayer surface and reversibly assemble into
aggregates of 6 6 2 antibiotic molecules.
INTRODUCTION
Amphotericin B (AmB) and nystatin are two structurally
similar polyene macrolide antibiotics characterized by a very
low antibacterial activity and a potent broad-spectrum anti-
fungal action (Bolard, 1986). Aftermore than 40 years after its
discovery, AmB still is the most common antifungal agent
used to treat systemic fungal infections (Hartsel and Bolard,
1996). However, several side effects, especially nephrotox-
icity, have restricted its use and promoted the development of
various liposomal formulations to minimize these problems
(Schaffner, 1984). Nystatin, on the other hand, is only used
topically, as it is ineffective orally and severely toxic when
administered intravenously (Schaffner, 1984). To be able
to develop rationale strategies to circumvent the severe
secondary effects caused by these antibiotics, it is essential to
obtain a detailed picture of their mode of action at the
molecular level.
The most widely accepted model for the mechanism of
action of these antibiotic molecules considers that their
cellular target is the plasma membrane of the antibiotic-sen-
sitive organisms where they act by forming aqueous pores
(Bolard, 1986; Hartsel et al., 1993). Several electrophysio-
logical studies have shown that bilayer-spanning potassium-
selective channels are formed upon one-sided addition of
nystatin or AmB to different lipid membranes (Akaike and
Harata, 1994). These pores have size-discriminating proper-
ties, being permeable only to solutes not larger than glucose or
sucrose for nystatin and AmB, respectively (Andreoli et al.,
1969; Holz and Finkelstein, 1970). The disturbance of the
cellular electrochemical gradients caused by the increase of
cell permeability to ions and small molecules ultimately leads
to cell lysis and death (Bolard, 1986). Despite the general
consensus about the antibiotic mode of action, there is still
some controversy regarding the molecular architecture of the
ion-permeable channels formed by these membrane-active
compounds. In particular, the role and even the indispens-
ability of sterols in the antibiotic self-assembly process that
occurs within the lipid bilayers are still matters of debate
(Hartsel et al., 1993). Some authors explain the sterol re-
quirement frequently found in nystatin and AmB activity
measurements by invoking the formation of transmembrane
pores constituted by antibiotic-sterol complexes composed of
alternated antibiotic and sterol molecules (Andreoli, 1974; de
Kruijff and Demel, 1974; van Hoogevest and de Kruijff,
1978). The distinct antibiotic sensitivities presented by
cholesterol-containing mammalian cells relative to ergos-
terol-rich fungal cells are therefore justiﬁed by the different
afﬁnities of the polyene antibiotics toward the sterol present in
the plasma membranes of the antibiotic-sensitive organism
(Bolard, 1986). On the other hand, other studies suggested
that the key factor controlling the ability of large polyene
antibiotic molecules to pack together is the overall membrane
organization. In this way, the formation of active antibiotic
species may be facilitated by the presence of an ordered state
in the lipid bilayer. This can be achieved either by the
progressive incorporation of a sterol in the membrane (Marty
and Finkelstein, 1975) or by keeping the lipid bilayers in a gel
phase (Hsu-Chen and Feingold, 1973).
Submitted September 25, 2002, and accepted for publication December
4, 2002.
Address reprint requests to Dr. Manuel Prieto, Centro de Quı´mica-Fı´sica
Molecular, Instituto Superior Te´cnico, Av. Rovisco Pais, P-1049-001
Lisbon, Portugal. Tel.: 3-51-21-841-9219; Fax: 3-51-21-846-4455; E-mail:
prieto@alfa.ist.utl.pt.
 2003 by the Biophysical Society
0006-3495/03/05/3061/18 $2.00
The presence of a conjugated double-bond system in the
chemical structure of the polyene antibiotics has enabled the
application of several optical spectroscopic techniques to
the study of the molecular structure of the channels formed
by these molecules in the lipid bilayers. The main spectros-
copies applied so far to AmB (with a heptanes group) were
ultraviolet-visible absorption and circular dichroism (CD)
(Bolard, 1986; Hartsel et al., 1993). The great potentialities
of these techniques derive from their ability to detect the
formation of several different antibiotic species in the
membranes, which are identiﬁed by a characteristic signature
spectrum. In addition, it is possible to evaluate the inﬂuence
that several parameters have on their occurrence, e.g., the
membrane-lipid composition (type of sterol and mole
fraction) and antibiotic-to-lipid ratios used (Bolard et al.,
1980; Vertut-Croquin et al., 1983). However, until recently
a quantitative analysis of the data obtained in most of these
studies was impaired by the complex equilibria present in the
samples that involved antibiotic aggregation in the aqueous
solution (Mazerski et al., 1982, 1990), partition into the lipid
bilayers (Szponarski et al., 1988) and self-association in
the lipid environment (Balakrishnan and Easwaran, 1993).
Fujii et al. (1997) were the ﬁrst to overcome this problem
by guaranteeing a complete association of AmB with the
liposomes used in all experimental conditions tested. From
a combination of functional assays with spectroscopic mea-
surements, these authors were able to show unequivocally
that a transition from the ion-impermeable to the ion-per-
meable state occurred concomitantly with signiﬁcant spec-
troscopic changes, indicating that two distinct forms of AmB
were present in the membranes, namely a monomeric and an
aggregated form (Fujii et al., 1997).
Regarding the application of optical techniques to the study
of polyene antibiotics mode of action, much less attention has
been paid to ﬂuorescence so far. However, from the anti-
cipated sensitivity of several ﬂuorescence parameters to the
properties of the ﬂuorophore microenvironment, this tech-
nique is also expected to be able to report changes of antibiotic
location/aggregation state in the lipid bilayer that are as-
sociated with the formation of active species (Strom et al.,
1976; Castanho and Prieto, 1992, Coutinho and Prieto, 1995).
In a previous work, we began to exploit the intrinsic
ﬂuorescence properties of the tetrane-containing antibiotic
nystatin (Coutinho and Prieto, 1995).We carried out a general
characterization of the photophysical behavior of nystatin
both in homogeneous media and in interaction with phos-
pholipid vesicles and established a comparison with the
photophysical properties of the well-studied tetrane ﬂuores-
cent fatty-acid trans-parinaric acid. Before addressing more
complex, and yet more biologically relevant lipid mixtur-
es—namely ergosterol- and cholesterol-containing lipid
bilayers—we have decided to extend the previous investiga-
tion of nystatin interaction with single component liposomes
to studies with small unilamellar vesicle (SUV) and large
unilamellar vesicle (LUV) prepared with DPPC and 1-pal-
mitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC). To
evaluate the inﬂuence exerted by the lateral packing of
phospholipids on nystatin interaction with the lipid vesicles,
several experiments were carried out with the lipid vesicles
kept in a gel phase. The creation of a lipid-ordered state by
adding sterol to a phospholipid at temperatures above the
phase transition would be a better in vitro model of
a biomembrane in a liquid-ordered phase. However, we
envisaged that the use of a gel phase would eventually allow
us to distinguish a general inﬂuence (the presence of lipid
ordered phase-gel phase, in this case) from a possible speciﬁc
effect (formation of speciﬁc antibiotic-cholesterol com-
plexes) on nystatin interaction with the lipid vesicles.
By measuring the ﬂuorescence decay curves of the lipid-
bound antibiotic molecules, nystatin was shown to form
strongly ﬂuorescent antibiotic aggregates in gel-phase mem-
branes that were dependent upon the antibiotic and lipid
concentrations used. These results were ascribed to a self-
association process undergone by the monomeric antibiotic
molecules within the lipid bilayer. Since it is believed that the
assembly of the large polyene antibiotics into conducting
pores plays a key role in their biological activity (Bolard,
1986), we decided to further characterize the factors con-
trolling nystatin oligomerization in the lipid vesicles. By
carrying out experiments with DPPC liposomeswith different
outer diameters (SUV and LUV), we were able to show that
the emission decay kinetics of the antibiotic was governed by
the mean number of membrane-bound nystatin molecules per
lipid vesicle and not strictly by its surface density.
MATERIALS AND METHODS
Reagents
Nystatin (pharmaceutical grade) was a gift from Squibb Farmaceˆutica
Portuguesa and was used without further puriﬁcation. DPPC and POPCwere
purchased from Avanti Polar Lipids (Alabaster, AL). The spin labels 5- and
16-doxyl-stearic acids (5-DS and 16-DS, respectively) were obtained from
Molecular Probes (Eugene, OR). All other chemicals were of analytical or
spectroscopic reagent grade.
The antibiotic was stored in the dark at 208C. A stock solution of
nystatin in methanol (spectroscopic grade) (;1 mM) was also stored at
208C in the dark before being used. Its concentration was determined by
UV spectroscopy using an absorption coefﬁcient of 7.4 3 104 M1 cm1 at
304 nm (Coutinho and Prieto, 1995). The stock solutions of n-DS were also
prepared in methanol (8 and 6 mM for 5-DS and 16-DS, respectively) and
kept at 208C.
Vesicle preparation
SUV were prepared by ultrasonic irradiation using a Branson 250 sonicator
with a standard ﬂat tip as described elsewhere (Coutinho and Prieto, 1995).
The standard buffer used was HEPES buffer (20 mM HEPES-NaOH (pH
7.4), 150 mM NaCl, 1 mM EDTA) but some lipid suspensions were also
prepared using a Tris buffer (50 mM Tris-HCl (pH 7.4), 10 mM NaCl, 0.2
mM EDTA). By means of the extrusion technique (Mayer et al., 1986) we
prepared LUV with a mean diameter of 100 nm. Brieﬂy, the lipid was
dissolved in chloroform in a round-bottom ﬂask and the solvent was ﬁrst
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dried under a stream of N2 and then further evaporated overnight under an
oil pump vacuum. The dried lipid was dispersed to the desired concentration
by adding the appropriate volume of the standard buffer and by repeated
vortexing at 508C, well above the gel-to-liquid crystalline phase transition
temperature (Tm) of the lipids used, until all lipid was removed from the
ﬂask wall. Then a freeze-thaw cycle was repeated eight times. Subsequently,
the lipid suspension was extruded four and 10 times through polycarbonate
membranes of 400- and 100-nm pore size (Nucleopore, Pleasanton, CA),
respectively. The resulting stock solution was stored at 48C. The ﬁnal lipid
concentration was determined by phosphate analysis (McClare, 1971).
Nystatin partitioning experiments
The partitioning of nystatin into the lipid bilayer was determined through the
ﬂuorescence intensity increase of the antibiotic’s tetrane group with the lipid
concentration measured in 0.5-cm cuvettes at 21 or 458C. Due to the high
susceptibility of nystatin to photochemical degradation, several dilutions of
a stock solution of SUV or LUV (;5 mM) were prepared with buffer. Then,
a constant volume from nystatin stock solution was injected to each of these
samples. The ﬁnal volume of methanol in solution never exceeded 1.5% of
the total volume of each sample. After an incubation time of 1 h in the dark
and at room temperature, the ﬂuorescence signal of each sample was
monitored as a function of the lipid concentration used. The contribution of
the liposomes alone was subtracted from this intensity.
The partitioning experiments were analyzed according to Eq. 1 (White
et al., 1998):
DI ¼ DImax½Lav½W=Kp1 ½Lav
: (1)
In this equation, DI ¼ I  I0 stands for the difference between the steady-
state ﬂuorescence intensity of the antibiotic measured in the presence (I ) and
in the absence of phospholipid vesicles (I0); DImax ¼ I‘  I0 is the
maximum value of this difference, since I‘ is the limiting value of I
measured upon increasing the lipid concentration, [L], of the solution; Kp is
the mole-fraction partition coefﬁcient of the antibiotic between the aqueous
and lipid phases and [W ] is the molar concentration of water. It was
assumed that only 60% and 50% of the overall lipid used was available,
[L]av, for the initial partition of the antibiotic in the experiments carried out
with SUV and LUV, respectively.
Quenching studies
The experiments were carried out with 3 mM DPPC SUV incubated with
either 3.0 or 12.5 mM nystatin for 1 h at room temperature. The antibiotic-
labeled lipid suspensions were divided into several samples and variable
aliquots from a methanolic stock solution of either spin probe (5- or 16-DS,
respectively) were then added to obtain different ﬁnal quencher concen-
trations for each sample. After another incubation time of 1 h at room
temperature, the steady-state ﬂuorescence intensity of nystatin in each
sample was measured at 218C. The volume of organic solvent did not
surpass 3.0% of each sample total volume. On the other hand, the highest
mole fraction of spin-labeled fatty acids used never exceeded 4–6% of the
phospholipid present in the outer monolayer of the liposomes.
Quenching data were analyzed by the Stern-Volmer plot of I0/I versus
[Q]l, where I0 and I stand for the ﬂuorescence intensities in the absence and
in the presence of the quencher, respectively, and [Q]l is the quencher (spin
label) concentration in the phospholipid phase,
½Ql ¼
K9pQ
11K9pQg½L
 
½Q; (2)
where K9pQ ¼ ½Ql=½Qw is the Nernst partition coefﬁcient of the quencher
between the phospholipid phase and the aqueous phase, [Q] is the bulk
molar concentration of the quencher (relative to the total sample volume, Vt
(Vt ¼ Vl 1 Vw)) and Vl and Vw are the volumes of the lipid and aqueous
phases, respectively. For 5-DS and 16-DS, K9pQ is 12,570 and 3340,
respectively, for the lipid vesicles in the gel phase (Wardlaw et al., 1987) and
a phospholipid molar volume, g, of 0.688 dm3mol1 was used for DPPC
(Marsh, 1990).
Absorption and steady-state
ﬂuorescence measurements
Absorption spectra were measured at room temperature using a Jasco V-560
spectrophotometer. Fluorescence measurements were made on a Spex
F112A Fluorolog photon-counting instrument (Edison, NJ) under the control
of a IBM PC equipped with the software DM3000, using a 150-W Xenon
light source, as previously described (Coutinho and Prieto, 1995). The
spectroﬂuorometer was equipped with a thermostated cuvette holder (618C)
and 0.5 cm pathlength quartz cuvettes were used. The conditions used in
most measurements were lexc¼ 315 nm (bandwidth 0.9 nm) and lem¼ 415
nm (bandwidth 9 nm). Stray light was reduced using an ultraviolet band-pass
ﬁlter SB-300 (Corion) in the exciting beam and a WG-360 (Corion) cutoff
ﬁlter in the emission beam.Moreover, background intensities in nystatin-free
samples due to the lipid vesicles were subtracted from each recording of
ﬂuorescence intensity. All the ﬂuorescence measurements were carried out
with a right-angle geometry, and the geometry effect was taken into account
when necessary (Coutinho and Prieto, 1995).
Nystatin aggregation in Tris and HEPES buffers and the detection of
vesicle aggregation or fusion induced by the antibiotic were studied by
measuring the light-scattered intensity by the antibiotic solutions or vesicle
suspensions, respectively, at lexc ¼ lem ¼ 450 nm (detected at 908).
Time-resolved ﬂuorescence measurements
Fluorescence lifetimes were determined by the single-photon timing
technique using a nitrogen-ﬁlled ﬂashlamp (Edinburgh Instruments, 119F)
as described previously (Coutinho and Prieto, 1995). The measurements
were done using lexc¼ 316 nm and lem¼ 415 nm with bandwidths of 4 and
8 nm, respectively. Fluorescence intensity decay curves were analyzed by
nonlinear least-squares regression, ﬁtting to the data a sum of exponentials,
IðtÞ ¼ +
n
i¼1
aie
t=ti ; (3)
where ai and ti are the normalized amplitude (+i ai ¼ 1) and lifetime of the
ith decay component, respectively. The reduced chi-squared value (x2) and
weighted residuals with their autocorrelation were used as best ﬁt criteria.
The range of chi-squared values obtained was 1.0–1.3.
The intensity-weighted mean ﬂuorescence lifetime, hti, is given by Eq. 4:
hti ¼ +
n
i¼1
fiti; (4)
where fi, the fractional intensity of the ith decay component, is:
fi ¼ aiti+n
i¼1 aiti
: (5)
On the other hand, t is the amplitude-weighted mean ﬂuorescence
lifetime,
t ¼ +
n
i¼1
aiti; (6)
or the lifetime-weighted quantum yield, since it is directly proportional to the
area under the decay curve (Lakowicz, 1999).
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Parameters that describe the occupation of
lipid vesicles with nystatin
To identify the controlling parameter of nystatin self-association in the
lipid vesicles, two different quantities were calculated for each sample
studied. The ﬁrst one was the phospholipid-to-antibiotic surface molar
ratio, RS,
Rs ¼ ½Lav½NMl 
; (7)
where ½NMl  ¼ nMl =Vt, the concentration of monomeric membrane-bound
nystatin, is given by
½NMl  ¼ xl½N; (8)
[N] is the bulk molar concentration of antibiotic and xl is the membrane-
bound mole fraction of monomeric antibiotic molecules:
xl ¼ Kp½Lav½W1Kp½Lav
: (9)
It should be noted that in these calculations it is implicitly assumed that
1), only monomeric antibiotic molecules partition between the aqueous
phase and the external lipid monolayer of the lipid vesicles; and 2), the mole
fraction of antibiotic molecules involved in oligomer formation is so small
that it can be ignored.
When liposomes with variable diameters are used, it is also useful to
compute hAi, the mean number of antibiotic molecules associated with
a lipid vesicle. hAi is readily derived from RS and m, the average number of
lipid molecules per vesicle:
hAi ¼ mxav
Rs
: (10)
xav is the fraction of lipid molecules in the outer half of a lipid vesicle.
For SUV and LUV we estimated m ¼ 6 018 and m ¼ 82 045, respectively
(Table 1).
Simulations of antibiotic binding
to the lipid vesicles
As indicated in the Discussion section, it was assumed that two basic steps
were involved in the interaction of nystatin with the lipid vesicles. First,
monomeric nystatin associates with the membrane. This ﬁrst step can be
described by a partition equilibrium of nystatin between the aqueous and the
membrane phases:
Kp ¼ ð½NMl =½LÞ=ð½NMw =½WÞ; (11)
whereKp is the mole-fraction partition coefﬁcient of the antibiotic, ½NMl  and
½NMw  are the bulk molar concentrations of monomeric antibiotic in the lipid
(i ¼ l) and aqueous (i ¼ w) phases, respectively, and [L] and [W ] are the
molar concentrations of lipid and water, respectively (White et al., 1998).
After partitioning into the lipid vesicles, the membrane-bound antibiotic
molecules may reversibly assemble into aggregates. The association con-
stant for the conversion of monomers into an aggregated form, a z-mer,
is given by
Kag ¼ hN
Ag
l i
hNMl iz
; (12)
where NMl and N
Ag
l represent the two different kinds of ﬂuorescent antibiotic
species that may be present in the liposomes, namely monomeric and oli-
gomeric nystatin. Each aggregate is formed by z antibiotic molecules. The
concentration unit chosen to describe this equilibrium was the mean number
of membrane bound antibiotic molecules per liposome.
The mass conservation law for the antibiotic is
nMw 1 n
M
l 1 zn
Ag
l ¼ nAt ; (13)
where nAt represents the total amount (i.e., number of moles) of antibiotic,
nMi are the amount of monomeric nystatin molecules present in each phase (i
¼ w, aqueous phase; i ¼ l, lipid phase, respectively), and nAgl is the amount
of aggregates formed by nystatin molecules in the lipid vesicles.
For any lipid or antibiotic concentration used, both the partition (Eq. 11)
and nystatin association equilibria (Eq. 12) must be simultaneously obeyed.
Combination of Eqs. 11 and 12 with the mass balance equation (Eq. 13)
results in:
zK9agðnMl Þz1 11
½W
Kp½Lac
 
nMl  nAt ¼ 0; (14)
where
K9ag ¼ n
Ag
l
ðnMl Þz
¼ Kag nlNA
m
 1z
; (15)
with NA, [L]av, nl, and m being the Avogadro’s number, the lipid
concentration available to the antibiotic binding, the amount of lipid
molecules in a sample and the number of lipids forming a single liposome,
respectively. Generally, this polynomial of zth-order (Eq. 14) has no
analytical resolution and therefore the simulation of nystatin binding to the
lipid vesicles had to be performed by an iterative numerical technique. For
the initial simulations, the antibiotic was assumed to undergo a cooperative
aggregation to an hexamer (z ¼ 6) and the partition coefﬁcient of nystatin
was set equal to its experimental value. After assigning a numerical value to
Kag, the mass balance equation was solved using the routine Solve for from
Quattro Pro Version 5.0 to calculate the mole fractions of each antibiotic
population present in the system
xMw ¼
nMw
nMw 1 n
M
l 1 zn
Ag
l
; (16)
xMl ¼
nMl
nMw 1 n
M
l 1 zn
Ag
l
; (17)
and
xAgl ¼
znAgl
nMw 1 n
M
l 1 zn
Ag
l
: (18)
RESULTS
Nystatin interaction with DPPC and POPC LUV
In a previous study of nystatin interaction with gel phase
TABLE 1 Summary of the physical characteristics
considered for the lipid vesicles used
Model system of membranes Mean diameter (nm) m
SUV 30 6.0 3 103
LUV 100 8.2 3 104
The calculation of the average number of lipids in a single liposome, m, was
based upon a 4.5-nm bilayer thickness, an average surface area occupied by
each phospholipid molecule of 0.7 nm2 (ﬂuid phase) (Marsh, 1990; Nagle
and Wiener, 1988) and assuming an homogeneous population of spherical
lipid vesicles. It was also considered that there were no phospholipid
packing constraints in the smaller vesicles and that the temperature did not
inﬂuence the average number of lipids per liposome (Cornell et al., 1981).
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DPPC SUV anomalous binding curves were obtained for this
antibiotic when high antibiotic concentrations (6.5, 7.8, and
13.5 mM) were used in some experiments (Coutinho and
Prieto, 1995). It was then shown that the steady-state
ﬂuorescence intensity of the antibiotic leveled off toward
a plateau, or even decreased sharply upon increasing the lipid
concentration, while nystatin overall concentration was kept
constant. The deviations presented by these experimental
binding curves from the expected hyperbolic behavior (Eq.
1) were then tentatively ascribed to the fusion/aggregation of
these lipid vesicles induced by the antibiotic molecules
(Coutinho and Prieto, 1995). Therefore, in this work DPPC
and POPC LUV were used in nystatin binding studies to
avoid these problems. In fact, it is well known that an
important characteristic of the model membrane system used
is its diameter since the curvature radius of the lipid vesicles
modulates its phospholipid packing, thereby conditioning its
interfacial properties and stability (Chrzeszczyck et al., 1977;
Brouillette et al., 1982). Considering that LUV prepared by
the extrusion procedure through ﬁlters with pores of 100 nm
have an outer diameter that is almost 3–4 times larger than
SUV prepared by sonication, we expected these vesicles to
be more stable and not so prone to undergo morphological
changes.
The relative increase in the steady-state ﬂuorescence in-
tensity of nystatin in the presence of DPPC LUV was used to
quantify its phospholipid/water partition coefﬁcient (Fig. 1).
It was considered that only the external monolayer of the
lipid vesicles was accessible to the antibiotic incorporation
because Finkelstein and co-workers (Marty and Finkelstein,
1975; Kleinberg and Finkelstein, 1984) have shown that the
pores formed from one-sided and two-sided addition of
nystatin to black lipid membranes had different properties. If
an equilibrium distribution of antibiotic molecules among
the two halves of the lipid bilayer was rapidly reached due to
a fast ﬂip-ﬂop rate, the method used in antibiotic delivery
should not inﬂuence the ﬁnal results, contrary to what was
observed experimentally. From a two-parameter ﬁtting
procedure (DImax and Kp, Eq. 1), a Kp ¼ (1.1 6 0.3) 3
104 was obtained for nystatin interacting with these lipid
vesicles in the gel phase (Table 2). This partition coefﬁcient
was independent of the antibiotic concentration used (Fig. 1)
at variance with what was previously reported for the ex-
periments carried out with DPPC SUV (Coutinho and Prieto,
1995). In addition, light-scattering measurements provided
no evidence for vesicle fusion/aggregation induced by the
antibiotic binding (results not shown). Similar partition
coefﬁcients for ﬂuid lipid vesicles, either DPPC LUV at
458C (Kp ¼ (0.9 6 0.1) 3 104) or POPC LUV at 218C
(Kp ¼ (1.4 6 0.2) 3 104, were also determined for nystatin
(Table 2).
Regarding the photophysical behavior of nystatin, the
ﬂuorescence decay curves of the antibiotic obtained in the
presence of DPPC and POPC LUV at 218C were both well
described by a sum of three exponentials as judged from the
ﬁtting criteria used (x2 value, random-weighted residuals
and autocorrelation plots; see also Table 3). In the presence
of gel-phase lipid vesicles, the ﬂuorescence emission decay
kinetics of nystatin was dominated by two long-lived decay
components ;14 and 43 ns that, together, accounted for
nearly 95% of the antibiotic ﬂuorescence intensity (Table 3).
In addition, the ﬂuorescence decay parameters of nystatin
were found to be independent of the antibiotic concentration
used (Table 3), the mean ﬂuorescence lifetime of the anti-
biotic (hti  36 ns) being close to the largest values pre-
viously measured for nystatin in interaction with gel-phase
DPPC SUV (Coutinho and Prieto, 1995). When the lipid
vesicles were in a ﬂuid phase (1 mM POPC LUV), the short-
lived ﬂuorescent antibiotic species detected (hti ¼ 5.9 ns)
was also found to be concentration independent (Table 3). In
FIGURE 1 Determination of the partition coefﬁcient of nystatin from its
ﬂuorescence intensity increase upon incorporation into LUV of DPPC at
218C. The nystatin concentrations used were (s) 3.2 and (d) 7.9 mM. The
solid line is the best ﬁt of Eq. 1 to the experimental data with Kp ¼ (1.1 6
0.3) 3 104.
TABLE 2 Mole-fraction partition coefﬁcients of nystatin,
Kp, for different phospholipid vesicles and temperatures
Model system
of membranes Phospholipid T (8C) Buffer Kp (310
4)
SUV DPPC 21 Tris 6.5 6 0.8*
HEPES 5.8 6 0.7
45 Tris 1.4 6 0.3
HEPES 1.6 6 0.3
LUV DPPC 21 HEPES 1.1 6 0.3
45 HEPES 0.9 6 0.1
POPC 21 HEPES 1.4 6 0.2
Partition coefﬁcients were obtained from steady-state ﬂuorescence intensity
data as described in Materials and Methods. It was considered that only
60% and 50% of the total lipid of SUV and LUV could interact with the
antibiotic, respectively.
*Coutinho and Prieto (1995).
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this case, however, a strong correlation between the ﬁtting
parameters (pre-exponentials and lifetimes) prevented an
accurate description of each individual ﬂuorescence decay
curve. Therefore, a global analysis of the experimental data
was carried out through linking the lifetimes between all
ﬂuorescence intensity decay curves. The global ﬁt was
considered satisfactory due to the low individual and global
x2 values obtained as well as by the random distributions of
the weighted residuals for each ﬂuorescence decay curve
(data not shown), and three lifetime components of 1.2, 5.2,
and 9.5 ns were recovered for nystatin (Table 3). The fast
decaying ﬂuorescent antibiotic species formed in these con-
ditions had a mean ﬂuorescence lifetime close to the one
obtained for nystatin in interaction with DPPC SUV at 458C
(hti ¼ 2.8 ns; see Coutinho and Prieto, 1995).
Detection of nystatin oligomers in gel-phase
lipid vesicles by time-resolved
ﬂuorescence measurements
The photophysical properties of nystatin in interaction with
gel phase DPPC SUV were previously found to be very in-
teresting because its intensity-weighted mean ﬂuorescence
lifetime increased sharply with the antibiotic concentra-
tion used (Coutinho and Prieto, 1995). This behavior was
interpreted as due to a cooperative oligomerization of the
antibiotic in the phospholipid bilayer. If this assumption is
correct, then the ﬂuorescence emission decay kinetics of
nystatin should be critically dependent upon the surface
density of antibiotic molecules adsorbed to the lipid vesicles.
To conclusively check this point, some additional time-
resolved ﬂuorescence experiments were carried out using
different antibiotic and phospholipid concentrations. But
ﬁrst, to avoid a signiﬁcant aggregation of the antibiotic in the
aqueous solution that would unnecessarily complicate the
interpretation of the experimental data, we exchanged the
buffer system used. Light-scattering measurements of
nystatin aqueous solutions prepared with HEPES buffer
were found to be essentially independent of the antibiotic
concentration used within 0–30 mM in contrast to what was
previously found with the Tris buffer (Fig. 2 B). Further-
more, a sharp increase in the ﬂuorescence intensity of the
antibiotic above a concentration ;3 mM was detected only
when nystatin aqueous solutions were prepared in Tris buffer
(Fig. 2A). This data indicates that large ﬂuorescent antibiotic
aggregates are not formed in HEPES buffer, and therefore
this was the buffer system chosen to carry out all the
subsequent experiments. The higher ionic strength of the
HEPES buffer solution must screen the electrostatic inter-
actions between the charged groups of the antibiotic, thereby
preventing an extensive self-association of the antibiotic
in aqueous solution, in agreement with what was previously
shown for AmB (Mazerski et al., 1990). On the other hand,
it was also found that nystatin partition coefﬁcients for
DPPC SUV were essentially independent of the buffer used
at both temperatures studied (T¼ 21 and 458C; see Table 2).
The ﬂuorescence decay parameters obtained for nystatin
in interaction with different phospholipid concentrations of
DPPC SUV are presented in Table 4. The main result of this
experiment was that upon increasing the lipid concentration
TABLE 3 Fluorescence intensity decay parameters for
nystatin in interaction with 1 mM LUV prepared with
different phospholipids (T 5 218C)
Phospholipid f1 t1 (ns) f2 t2 (ns) f3 t3 (ns) hti (ns)
DPPC* 0.06 1.9 0.15 14 0.79 43 36
POPCy 0.20 1.2 0.45 5.2 0.35 9.5 5.9
fi and ti are the fractional ﬂuorescence intensity and lifetime, respectively,
of each decay component. hti is the intensity-weighted mean ﬂuorescence
lifetime of the antibiotic. The liposomes were prepared in HEPES buffer.
*The decay components were independent of nystatin concentration
between 1.9 and 12.5 mM. f1, 60.01; t1, 60.6; f2, 60.02; t2, 61.0; f3,
60.03; t3, 61.0; hti, 61.0.
yThe ﬂuorescence intensity decays were independent of nystatin concen-
tration between 3.5 and 12.5 mM. They were globally analyzed by linking
the lifetimes of each ﬂuorescence intensity decay (n ¼ 7), a x2g of 1.1 being
obtained. f1, 60.01; f2, 60.02; f3, 60.04; hti, 60.2.
FIGURE 2 Variation of (A) the steady-state ﬂuorescence intensity, If
(lexc ¼ 304 nm; lem ¼ 410 nm) and (B) light scattering intensity, Id (lexc ¼
lem ¼ 450 nm), with nystatin concentration in (d) Tris and (s) HEPES
buffers.
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used there was a pronounced shift in the antibiotic critical
concentration where nystatin photophysics switched from
a fast to a slow decaying ﬂuorescent species (from ;5 to
12 mM nystatin at 1.1 and 3.5 mM DPPC SUV, respectively;
see Table 4). In either case, the alteration in nystatin pho-
tophysics was mainly caused by an enhancement in the
fractional ﬂuorescence emission intensity of the longest-
lived decay component of the antibiotic upon an increase of
its bulk molar concentration in solution (Table 4), in con-
formity with what was previously reported (Coutinho and
Prieto, 1995).
To test the former hypothesis, i.e., that the controlling
parameter of nystatin assembly in the lipid vesicles was the
surface density of membrane-bound antibiotic molecules, it
was essential to correct the experimental data for the variable
mole fraction of nystatin partitioned into the liposomes
(which is dependent upon the phospholipid concentration
used; see Eq. 9). Fig. 3 shows that the computation of the
phospholipid-to-antibiotic surface molar ratio, RS, according
to Eq. 7 allowed for a uniﬁed description of the experimental
data obtained with DPPC SUV because the appearance of
a long-lived ﬂuorescent antibiotic species is now shown to
occur within a rather narrow range of nystatin surface
densities, 150\RS\ 280. Furthermore, the alterations de-
tected in nystatin ﬂuorescence decay kinetics are also shown
to be essentially independent of the method used to prepare
the samples, i.e., either keeping the phospholipid concentra-
tion constant and varying the antibiotic concentration (Fig. 3
A) or vice versa (Fig. 3 B). Therefore, it seems that the
photophysical behavior of nystatin is controlled by the
surface concentration of monomeric antibiotic molecules
partitioned into the small unilamellar vesicles, and it is
not dependent upon the presence of preformed antibiotic
aggregates in the aqueous solution.
To compare the data obtained with gel-phase DPPC SUV
and LUV it was further necessary to take into account the
different partition coefﬁcients obtained for each model lipid
bilayer system used (Table 2). After taking this point into
consideration, one would expect that the mean ﬂuorescence
lifetime of nystatin as a function of RS should follow the
same general trend in both cases if nystatin photophysical
behavior was solely determined by the surface density of the
adsorbed antibiotic molecules. However, contrary to the
expectations, Fig. 4 A shows that it was not enough to keep
the same phospholipid-to-antibiotic surface molar ratio in the
two membrane systems to get a similar mean ﬂuorescence
lifetime for nystatin. In fact, even when very diluted anti-
biotic surface concentrations were reached with DPPC LUV
(RS  280), there still was no signiﬁcant decrease in hti.
Why is the photophysical behavior of nystatin distinct
when the antibiotic interacts with LUV instead of SUV? A
possible explanation is that its ﬂuorescence emission decay
kinetics is controlled by the antibiotic-to-liposome ratio
instead of its surface concentration. In fact, a SUV with an
average outer diameter of 30 nm consists of ;6000 lipid
molecules compared to ;82,000 for a LUV with an average
outer diameter of 100 nm (Table 1). Consequently, although
the total surface area of all the SUV in a lipid suspension is
only 1.2 times larger than that of LUV at the same lipid
concentration, there is ;14 times more SUV than LUV in
solution (note that the outer surface area of a LUV is ;11
times larger than the one from a SUV). Therefore, and as
a test for the former hypothesis, we replotted the data as hti
versus the mean number of membrane bound antibiotic
molecules per liposome, hAi (Eq. 10). Fig. 4 B supports the
view that indeed the transition from a monomeric to an
aggregated state of the antibiotic is essentially controlled by
the mean occupation number of a lipid vesicle since the
TABLE 4 Fluorescence intensity decay parameters for nystatin in interaction with SUV of DPPC as a function of
phospholipid and antibiotic concentration (T 5 218C)
[DPPC] (mM) [Nystatin] (mM) f1 6 0.07 t1 (ns) 6 0.8 f2 6 0.05 t2 (ns) 6 1.3 f3 6 0.05 t3 (ns) 6 3 hti (ns) 6 2
1.1 1.9 0.20 1.4 0.66 7.0 0.14 29 9.0
3.8 0.24 2.7 0.54 7.9 0.22 28 11
4.7 0.20 2.3 0.51 8.2 0.29 33 14
5.4 0.16 2.7 0.30 10 0.54 38 24
6.3 0.12 2.5 0.27 10 0.61 38 26
6.7 0.11 2.4 0.24 10 0.65 38 27
7.9 0.08 1.9 0.23 10 0.69 39 29
9.4 0.11 1.9 0.20 12 0.69 40 30
12.5 0.08 2.1 0.20 12 0.72 40 31
3.5 3.2 0.36 3.0 0.60 8.0 0.05 28 7.3
4.7 0.33 2.6 0.60 8.1 0.07 28 7.7
6.3 0.29 2.6 0.61 7.9 0.10 27 8.3
7.9 0.24 2.7 0.56 8.2 0.19 32 11
9.4 0.24 2.8 0.54 8.3 0.23 33 13
11.0 0.26 2.9 0.48 8.7 0.25 34 13
12.5 0.09 2.9 0.29 9.9 0.62 37 26
14 0.08 2.4 0.22 11 0.70 39 30
fi and ti are the fractional ﬂuorescence intensity and lifetime, respectively, of each decay component. hti is the intensity-weighted mean ﬂuorescence lifetime
of the antibiotic. The liposomes were prepared in HEPES buffer.
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experimental data now describes a curve that is essentially
independent of the model membrane system used. However,
due to the complexity of the system, it cannot be ruled out
that other factors, e.g., the curvature of the lipid vesicles, are
also inﬂuencing nystatin oligomerization, as it will be dis-
cussed below. Fig. 4 B further shows that there is a threshold
value for the mean occupation number of the lipid vesicles,
hAi* 10, above which the long-lived ﬂuorescent antibiotic
species starts to be formed in the gel-phase lipid vesicles.
This data is also a deﬁnitive demonstration that the inclusion
of sterols in the composition of a lipid vesicle is not an ab-
solute prerequisite for nystatin oligomerization to take place.
Fluorescence quenching studies of nystatin
by 5- and 16-DS
To estimate the antibiotic location in the lipid vesicles,
a ﬂuorescence quenching study of nystatin by two lipophilic
probes, 5- and 16-DS, was carried out. These two spin-
labeled fatty acids are known to insert predominantly
vertical to the bilayer surface of the lipid vesicles (Ellena
et al., 1988). Therefore their doxyl groups are located at
different depths in the lipid bilayer (Fig. 5; see also Ellena
et al., 1988; Feix et al., 1984), allowing information about
the transversal position of the antibiotic ﬂuorophore in the
lipid vesicles to be obtained. The ﬂuorescence quenching
study of nystatin was carried out with DPPC SUV at 218C
using two different antibiotic concentrations, 3.0 and 12.5
mM. As these antibiotic samples have very different mean
FIGURE 3 Relationship between the mean ﬂuorescence lifetime of
nystatin, hti, and the phospholipid-to-antibiotic surface molar ratio, RS,
obtained with SUV of DPPC at 218C. (A) The phospholipid concentration
was kept constant (s) 1.1 mM, (d) 1.6 mM, () 2.3 mM, (n) 2.4 mM, and
(m) 3.5 mM DPPC) while the antibiotic concentration was varied. (B) The
nystatin concentration was kept constant (.) 7.9 mM, (n) 9.4 mM, and (,)
11.0 mM antibiotic) while the phospholipid concentration was varied in each
experiment. The dashed vertical lines deﬁne the range of RS values (150\
RS\ 280) correspondent to the transition region between a long and short
mean ﬂuorescent lifetimes of nystatin.
FIGURE 4 Mean ﬂuorescence lifetime of nystatin, hti, at different (A)
surface molar ratios of phospholipid-to-antibiotic, RS, and (B) mean number
of membrane bound antibiotic molecules per liposome, hAi. The model
membrane systems used were DPPC SUV (s) or LUV (d) at 218C. In some
experiments the phospholipid concentration was kept constant and the
antibiotic concentration was varied and vice versa (see Fig. 3, legend). The
solid line is the best ﬁt of the cooperative partition model of the antibiotic to
the experimental data (see the text and Fig. 8, legend, for details). (C, inset)
Plot showing the relationship between the lowest value of the root-mean-
square deviations (RMSD), and the aggregation number of nystatin, z. K9ag
was allowed to vary in each ﬁtting while z was kept constant at different
integer numbers (see Table 5).
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ﬂuorescence lifetimes (;10 and 28 ns, respectively), it was
anticipated that they might provide information regarding
the inﬂuence that the antibiotic aggregation state—mono-
mer or oligomer—had on its transversal position in the lipid
bilayer.
The Stern-Volmer plots for the steady-state ﬂuorescence
quenching study of nystatin by 5- and 16-DS in 3 mM
SUV of DPPC at 218C are depicted in Fig. 6. The actual
quencher concentrations in the phospholipid phase, [Q]l,
were computed from Eq. 2 and it was found that ;94%
and 81% of the 5-DS and 16-DS probes, respectively, were
partitioned into the lipid vesicles. It should also be noted
that with the lipid concentration used, ;30% of the anti-
biotic remained in the aqueous phase. However, this anti-
biotic mole fraction does not inﬂuence the interpretation
of the quenching experiments inasmuch as nystatin quantum
yield in this phase is negligibly small compared to its value
in the lipid phase (Coutinho and Prieto, 1995). Thus, its con-
tribution to the total ﬂuorescence intensity of the antibiotic
sample, and therefore to the measured ﬂuorescence quench-
ing, is not signiﬁcant. Fig. 6 A shows that the shallower
spin-labeled fatty acid 5-DS was a more effective quencher
of 3 mM nystatin than 16-DS, indicating a superﬁcial lo-
cation for the tetrane ﬂuorophore of the antibiotic. On the
other hand, upon increasing the antibiotic concentration to
12.5 mM, both spin-labeled fatty acids became equally ef-
fective in quenching nystatin ﬂuorescence (Fig. 6 B). Due
to the probable existence of more than one antibiotic popula-
tion in these samples, the interpretation of this quenching
data is not so straightforward as before and it will be
discussed in more detail in the Discussion section.
DISCUSSION
Nystatin interaction with different model lipid
bilayer systems
The main objective of this work was to evaluate the inﬂuence
that both the physical state of one-component phospholipid
bilayers and the type of lipid vesicle used had on nystatin
binding to the liposomes and its subsequent ability to re-
versibly assemble into aggregates. In a following study, the
effects exerted by sterols—cholesterol and ergosterol—on
both these processes will be described.
In the ﬁrst part of this work, the intrinsic ﬂuorescence
emission properties of the polyene antibiotic nystatin were
explored to characterize its binding to DPPC and POPC
vesicles. Two main differences were found between nystatin
interaction with DPPC SUV and LUV in the gel phase: 1),
nystatin was only able to induce the fusion/aggregation of
the smaller lipid vesicles (Coutinho and Prieto, 1995); and
2), the partition coefﬁcient of this antibiotic was;5–7 times
larger for SUV than for LUV in the gel phase (Table 2). The
most probable explanation for these results lies in the
nonequilibrium structure of SUV due to its small curvature
radius. In fact, it is well known that the size of a liposome has
a lower limit below which the curvature radius of its internal
monolayer is so small that packing constraints between the
phospholipid headgroups arise, preventing the formation of
smaller lipid vesicles and making the outer monolayer of
a SUV more expanded than the one obtained with a planar
lipid bilayer (Chrzeszczyck et al., 1977; Brouillette et al.,
1982). These structural characteristics of the SUV make
them thermodynamically unstable (Suurkuusk et al., 1976)
FIGURE 5 Schematic representation of the expected
transversal positions for the lipophilic probes 5- and 16-DS
in a lipidic membrane. The dashed line represents the
boundary between the polar and apolar regions of the
membrane. Nystatin is represented perpendicular to the
membrane surface just to illustrate that, upon internaliza-
tion, its ﬂuorophore group should get closer to both spin
probes.
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and more prone to undergo fusion/aggregation induced by an
active molecule (van Dijck et al., 1978). The interfacial
packing defects, which are more important in gel phase
SUV, also justify the larger partition coefﬁcient found for
nystatin toward DPPC SUV compared to DPPC LUV (Table
2) because they are expected to be preferential partitioning
sites for the antibiotic. In contrast, when the lipid vesicles
were in a ﬂuid phase an antibiotic partition coefﬁcient Kp 
(1.36 0.3)3 104 was always obtained (Table 2), which was
essentially independent of the type of phospholipid (DPPC
or POPC) or liposome (SUV or LUV) employed.
Bolard and co-workers had previously obtained similar
results with vacidin A (Bolard et al., 1984), an aromatic
polyene antibiotic, and with AmB (Milhaud et al., 1989).
These authors found that these polyene antibiotics had
a higher afﬁnity for gel phase relative to ﬂuid phase lipid
membranes only when the model lipid bilayer system used
were SUV. Furthermore, Bolard and Cheron (1982) showed
by gel ﬁltration and ultracentrifugation techniques that AmB
was only able to induce the fusion or aggregation of small
vesicles in the gel phase. When the lipid vesicles were in the
liquid-crystalline phase or when larger lipid vesicles were
used (although in the gel state), these processes did not
occur.
Fluorescence decay kinetics reports on nystatin
self-association in gel-phase lipid vesicles
Considering that the main factor governing nystatin photo-
physics is the aggregation state of the antibiotic in the lipid
vesicles (Coutinho and Prieto, 1995), one would expect its
mean ﬂuorescence lifetime to be controlled by the surface
density of membrane-bound antibiotic molecules in the
phospholipid vesicles. Although the ﬁrst experiments per-
formed to test this hypothesis seemed to conﬁrm this pre-
diction (Fig. 3), they were unable to explain why the mean
ﬂuorescence lifetime of the antibiotic interacting with DPPC
LUV was essentially independent of the phospholipid-to-
antibiotic surface molar ratio used, always presenting a large
value characteristic of the long-lived/aggregated antibiotic
species, even when very diluted samples were prepared
(Fig. 4 A). Further analysis of these results (Fig. 4 B) gave
support to a different hypothesis, namely that the formation
of highly ﬂuorescent oligomers by nystatin was controlled
by the mean occupation number of a lipid vesicle, hAi,
and not strictly by its phospholipid-to-antibiotic surfacemolar
ratio. For this to be possible, the rate of aggregate forma-
tion must be fast compared to the incubation time ($1 h) that
preceded the time-resolved ﬂuorescence measurement of
each sample. Tachyia (1987) deduced a relationship between
the mean reaction time, tm, of a pair of randomly distributed
molecules in the surface of a sphere (e.g., a micelle or a
lipid vesicle) and the sum of the radii of the sphere and the
reactant, r, and the sum of the diffusion coefﬁcients of both
reactants, D:
tm ¼ r
2
D
2
1 ðd=2rÞ2 ln
2r
d
 1
 
; (19)
with d being the sum of the radii of the reactants. If one
considers the worst situation of our studies, i.e., a lipid
vesicle with a radius of 50 nm (LUV) and D  1014 m2 s1
(lipids in the gel phase; Sackmann, 1983), we get tm  1 s.
Therefore, it is safe to conclude that even if the aggregates
formed are larger than a dimer, the incubation time used for
each lipid and antibiotic mixture must have been sufﬁciently
long for nystatin oligomerization reaction to attain its ﬁnal
equilibrium value even when the larger lipid vesicles were
used.
The time-resolved ﬂuorescence data also show that the
minimal number of monomeric-bound antibiotic molecules
required to be present in a lipid vesicle for the long-lived
ﬂuorescent antibiotic species to be formed is hAi* 10 (Fig.
4 B). It is important to note, however, that this parameter
corresponds to the antibiotic aggregation number in the
liposomes only if nystatin self-association in the lipid
vesicles is an irreversible process, which is not the case
FIGURE 6 Stern-Volmer plots for the steady-state ﬂuorescence quench-
ing study of nystatin by 5- and 16-DS in 3 mM SUV of DPPC at 218C. The
nystatin concentrations used were (A) 3.0 and (B) 12.5mM. Liposomes were
prepared in Tris buffer. Lines are drawn just to guide the eye.
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(Coutinho and Prieto, 1995). According to St. Pierre-
Chazalet and co-workers (St. Pierre-Chazalet et al., 1988)
and Seoane et al. (1997) the superﬁcial area occupied by
AmB in an antibiotic monolayer at the air/water interface is
1.8–1.9 nm2/molecule when the molecules are horizontal,
i.e., when their polar faces are anchored in the water and their
hydrophobic polyene chains are in contact with the air. On
the other hand, upon switching to an orientation perpendic-
ular to the interface (vertical form), the AmB molecules
occupy ;0.55 nm2/molecule. Considering that the surface
area of a DPPC molecule is 0.5 nm2 (gel phase; see Marsh,
1990), the performance of a simple calculation shows that for
this critical occupation number (hAi* ¼ 10), less than 1% of
the external surface area of a small unilamellar vesicle is
occupied by horizontally adsorbed nystatin molecules.
This hypothesis also provides an explanation for the ano-
malous binding curves obtained for this antibiotic when
small unilamellar gel-phase DPPC vesicles with high anti-
biotic concentrations were used (see Coutinho and Prieto,
1995; see also Results section, this article). In fact, the
formation of long-lived and highly ﬂuorescent antibiotic
oligomers in the liposomes at low liposome concentrations
(hAi  10) must be the cause for this puzzling behavior.
Upon increasing the lipid concentration in each sample, there
must have been a rapid exchange of antibiotic molecules
between the lipid vesicles causing the dissociation of these
aggregates (hAi  10). Since the monomeric membrane-
bound antibiotic molecules have a lower quantum yield than
the oligomers, the steady-state ﬂuorescence intensity of the
antibiotic samples stabilized, or even decreased, upon
increasing the lipid concentration in solution, contrary to
the theoretical expectation. These deviations were not no-
ticed with the lowest antibiotic concentration used in the par-
titioning experiments (4.2 mM nystatin; Coutinho and Prieto,
1995) because in this case the alterations in the ﬂuores-
cence emission decay kinetics of the antibiotic occurred at
a very low phospholipid concentration ( 0.5 mM). This
interpretation of the experimental data is further supported
by other studies that show the polyene antibiotics ability’s
to undergo a rapid distribution between the aqueous phase
and the lipid bilayers, either black lipid membranes (Cass
et al., 1970) or liposomes (Witzke and Bittman, 1984). The
spectroscopic CD studies carried out by Bolard et al. (1981)
have also shown the capacity of AmB to rapidly exchange
between DPPC SUV in the gel phase. Vertut-Croquin
et al. (1984) even took advantage of this property to change
the incorporation procedure of AmB into the lipid vesicles
from an injection of an antibiotic stock solution prepared
with an organic solvent to the utilization of liposomes pre-
loaded with AmB.
However, two major criticisms may be raised against the
hypothesis discussed above. First, a rigorous demonstration
of its validity would require testing if a slow-decaying
antibiotic species is obtained when nystatin samples are
prepared with DPPC LUV containing a mean antibiotic
occupation number below the determined critical value, i.e.,
hAi \10. Unfortunately, these measurements were ex-
tremely difﬁcult to perform with our experimental setup
because they would either require the use of a very low
antibiotic concentration (implying a large acquisition time
for the time-resolved ﬂuorescence measurement) or of a
very concentrated lipid suspension (that would originate an
important scattering contribution to the experimental data).
Therefore, it cannot be ruled out that the curvature radius of
the lipid vesicles used may play some role in nystatin oli-
gomerization. In fact, since this parameter determines the
lipid packing of the external monolayer of LUV and SUV, it
may also inﬂuence the penetration of the membrane surface
by nystatin molecules and, consequently, their ability to form
aggregates.
Secondly, it should be noted that the calculation of the
mean occupation number of the liposomes by the antibiotic
molecules was carried out using two major approximations:
1), it was admitted that both liposome suspensions, SUV and
LUV, consisted of an homogeneous population of lipid
vesicles; and 2), nystatin ability to induce the aggregation/
fusion of SUV was ignored. Both these factors must be
responsible, at least to some extent, for the scattering of hti
values displayed in Figs. 3 and 4, particularly the one pre-
sented by the samples prepared with the highest concen-
trations of antibiotic. However, their relative importance
on the ﬁnal result must not have been too severe, otherwise it
would not have been possible to normalize all the experi-
mental data by computing hAi for each sample, as it is shown
in Fig. 4 B.
Nystatin location in the lipid vesicles
Depth-dependent ﬂuorescence quenching studies of nystatin
with two lipophilic probes, 5- and 16-DS, were carried out
using two different antibiotic concentrations, namely 3.0 and
12.5 mM. These samples displayed distinct mean ﬂuores-
cence lifetimes (;10 and 28 ns, respectively) and therefore
they represented two different experimental situations: in the
ﬁrst case (3.0 mM nystatin; hAi ¼ 4.1), the bound antibiotic
molecules were predominantly monomeric in the lipid bi-
layer, whereas in the second case (12.5 mM nystatin; hAi ¼
17.0) a signiﬁcant fraction of the bound antibiotic molecules
was already engaged in the formation of oligomers with
a long-lived ﬂuorescence lifetime. Hence, it was anticipated
that these ﬂuorescence quenching studies could eventually
provide some information about nystatin assembly being ac-
companied by an internalization of the antibiotic molecules
from the bilayer surface toward its hydrophobic interior.
In the ﬁrst situation studied (hAi ¼ 4.1), it was concluded
that the monomeric antibiotic molecules reside near the
phospholipid/water interface since the Stern-Volmer plot
showed that the shallower spin-labeled fatty acid 5-DS was
a more effective quencher of the tetrane ﬂuorophore than
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the16-DS probe (Fig. 6 A). This location is compatible with
the fast ﬂuorescence decay kinetics presented by this
antibiotic species (hti  10 ns) because the surface-adsorbed
antibiotic molecules must not experience a very rigid en-
vironment upon membrane binding.
Since the same experimental methodology was also used
to determine the transverse location of ﬁlipin (Castanho and
Prieto, 1995), another polyene antibiotic, it is interesting to
compare both studies. Contrary to the present data, it was
reported that the spin-labeled fatty acid 16-DS was a more
efﬁcient quencher of the ﬂuorescence from the ﬁlipin pen-
tane group than the 5-DS probe. Therefore, it was con-
cluded that ﬁlipin location was in the inner region of the
membrane, near the phospholipid bilayer center. The dif-
ference between the preferred locations found for these two
polyene antibiotics must be related to their distinct chemi-
cal structures; whereas nystatin has a mycosamine residue at-
tached to its macrolide ring, the small polyene macrolide
antibiotic ﬁlipin does not. Hence, this sugar must be essential
in anchoring nystatin at the membrane surface due to its
polar character.
The analysis of the quenching data obtained in the second
situation studied (hAi ¼ 17.0) is necessarily more complex,
because two different antibiotic populations—monomers and
oligomers—co-exist in equilibrium in the lipid vesicles. In
addition to different ﬂuorescence quantum yields, these two
antibiotic populations most probably also have distinct
transverse locations in the lipidmembrane aswell as a variable
exposure of their tetrane groups to the quenchers used.
Ladokhin (1997) and Asuncion-Punzalan et al. (1998) have
already addressed some of these problems by considering the
effect of two populations of ﬂuorophores at different depths in
the lipid bilayer in the analysis of the quenching results. The
authors concluded that the information obtained about the
center of the transverse distributions of the molecules in the
liposomes reﬂected their average depth in the lipid bilayer
weighted by their respective ﬂuorescence quantum yields.
Considering that the oligomers formed by nystatin exhibit
a lifetime-weighted quantum yield ;53 higher than the
membrane-bound monomeric molecules (see next section),
the ﬂuorescence emitted by the 12.5mMnystatin samplemust
be dominated to a large extent by the long-lived aggregates
formed by nystatin. Therefore, it seems reasonable to assume
that the quenching results must reﬂect predominantly the
average location of the tetrane ﬂuorophore in these antibiotic
assemblies. Since both spin-labeled fatty acids quenched 12.5
mMnystatin ﬂuorescence nearly to the same extent (Fig. 6B),
it seems that nystatin oligomerization in the liposomes is
accompanied by a coordinate translocation of the antibiotic
molecules from the bilayer surface toward its center (Fig. 7).
On the other hand, it is expected that the self-association
undergone by nystatin in the liposomes must have shielded to
some extent the antibiotic ﬂuorophores from the spin-labeled
fatty acids used. However, this alteration in the ﬂuorophores
accessibility to the quenchers does not inﬂuence the in-
terpretation of the quenching data because the masking of the
quenching efﬁciencies is expected to be the same for both
spin-labeled fatty acids.
Cooperative partition model of nystatin
According to the previous discussion, the following model is
proposed for nystatin interaction with gel phase liposomes
(Fig. 7):
1. When nystatin is added to the aqueous solution at a
sufﬁcient low concentration, monomeric antibiotic mole-
cules adsorb predominantly at the phospholipid/water
interface. This surface location of the antibiotic does not
impose severe restrictions to the vibrational movements of
the macrolide ring of the antibiotic molecules, and
therefore their ﬂuorescence emission decay kinetics is
relatively rapid, i.e., the antibiotic presents a short mean
ﬂuorescence lifetime (hti  7–10 ns).
2. Upon increasing the antibiotic concentration added to
each sample, the membrane-bound antibiotic molecules
start to oligomerize. Since the antibiotic molecules are
putatively more rigidiﬁed in the antibiotic assemblies
formed in the lipid bilayer than in its monomeric form, its
nonradiative deactivation pathways decrease and its
ﬂuorescence emission decay kinetics becomes slower.
Therefore, the mean ﬂuorescence lifetime of nystatin
progressively increases from 7–10 ns to ;35 ns.
FIGURE 7 Schematic representation of the main stages of nystatin
interaction with gel-phase lipid vesicles. (i) After nystatin addition to
a liposome suspension, the monomeric antibiotic molecules partition into the
membrane-water interface of the lipid vesicles. (ii) When the mean number
of antibiotic molecules per liposome reaches a critical value (;10 for gel-
phase lipid vesicles), nystatin starts to self-associate. This process is
accompanied by an increase in nystatin mean ﬂuorescence lifetime from
7–10 ns to ;35 ns. Concurrently, nystatin molecules translocate from the
surface toward the interior of the lipid vesicles. The nystatin molecules that
form an oligomer must shield their polar groups from contact with the acyl
chains of the phospholipids.
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3. The quenching experiments support the hypothesis that
nystatin aggregation in the lipid vesicles is accompanied
by an internalization of the antibiotic molecules from the
lipid bilayer surface toward its center (Fig. 7). This re-
orientation of nystatin in the membrane must increase the
local perturbation exerted by the antibiotic molecules
upon the lipid bilayer structure. When SUV are used, this
effect is translated into an increased liposome aggrega-
tion/fusion induced by the antibiotic molecules.
The above model raises two important questions, both of
which deserve further consideration. The ﬁrst question is,
what is the effect of the interdependence between both
equilibria—nystatin partition and oligomerization—on nys-
tatin partitioning into the lipid vesicles? In fact, if both
equilibria must be obeyed simultaneously, they may in-
ﬂuence each other signiﬁcantly depending on the experi-
mental conditions employed (i.e., antibiotic and phospholipid
concentrations used). The second issue that must be con-
sidered is whether this model has the ability to reproduce the
general trends of the ﬂuorescence emission decay kinetics of
nystatin, even if only in a qualitative way. In particular, it is
important to assess if this model can predict the occurrence
of a critical value for the mean occupation number of
liposomes by nystatin, hAi*, as it was experimentally dem-
onstrated in this study (Fig. 4 B).
The ﬁrst problem was addressed by simulating the binding
of nystatin to gel-phase SUV as described in the Materials
and Methods section. Fig. 8 displays the results obtained in
one simulation where the lipid concentration was kept
constant (1 mM) while the antibiotic concentration was
varied between 1 and 14 mM. Kp was set equal to 9.23 10
4,
the experimentally determined partition coefﬁcient for 4.2
mM nystatin (gel-phase SUV, HEPES buffer; see Table 1;
see also Coutinho and Prieto, 1995). In addition, it was
assumed that nystatin reversibly assembled in the lipid
bilayer into hexamers (z ¼ 6) with an association constant
K9ag ¼ 3:73 104 mmol5 (Kag ¼ 3.73 10111; Eq. 15). Fig.
8 A shows that in these conditions there was an increasing
formation of oligomers by nystatin above an antibiotic con-
centration of ;4 mM. Concomitantly, there was a reduction
in the monomeric antibiotic mole fractions present both in
FIGURE 8 Simulation of the effect of nystatin self-association upon the
antibiotic binding to the lipid vesicles and its ﬂuorescence emission decay
kinetics. (A) Antibiotic mole fractions as a function of the bulk molar
nystatin concentration added to the SUV suspension: (s) xMw , (d) x
M
l , and
(n) xAgl (calculated according to Eqs. 16–18). x
M
w and x
M
l are coincident. (B)
Relationship between the partition coefﬁcient of the antibiotic and its total
concentration in solution. The dashed line depicts the value used for nystatin
partition coefﬁcient in this simulation (Kp ¼ 9.2 3 104), whereas (d)
represent Kapp (calculated according to Eq. 20). (C) Mean ﬂuorescence
lifetime computed for nystatin, hticalc, at different mean number of
membrane bound antibiotic molecules per liposome, hAi. This last
parameter was calculated according to Eq. 10 using either Kp (s) or K
ap
p
(d) in Eq. 9. The simulation of the cooperative partition model of nystatin
was done considering that i), only monomeric antibiotic molecules partition
into the liposomes ([L]t ¼ 1 mM; m ¼ 6,018; T ¼ 218C); and that ii),
nystatin self-associates into hexamers (z ¼ 6) with an association constant
Kag¼ 3.73 10111. hticalc was computed according to Eq. 27 considering for
monomeric nystatin aM1 ¼ 0.63; aM2 ¼ 0.36; aM3 ¼ 0.01; tM1 ¼ 2.6 ns;
tM2 ¼ 8.1 ns e tM3 ¼ 28 ns, and for the antibiotic molecules involved in
aggregate formation aAg1 ¼ 0.40; aAg2 ¼ 0.10; aAg3 ¼ 0.50; tAg1 ¼ 2.4 ns;
tAg2 ¼ 14.0 ns e tAg3 ¼ 42 ns.
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the aqueous solution and in the lipid vesicles (Fig. 8 A). The
main result from this simulation is therefore the demonstra-
tion that nystatin self-association in the lipid bilayer drives
a progressive recruitment of monomeric antibiotic molecules
from the aqueous phase, generating a cooperative partition of
the antibiotic molecules into the lipid vesicles. In fact, if we
deﬁne an apparent partition coefﬁcient for nystatin, Kapp , that
takes into account the z-mers in addition to the monomers
present in the lipid bilayer:
Kapp ¼
ðnMl 1 znAgl Þ=nl
nMw=nw
: (20)
It can be shown that its value gradually increases with the
antibiotic concentration used from the moment that nystatin
aggregation in the lipid bilayer starts to become important
(Fig. 8, A and B). This effect has already been demonstrated
experimentally in a different system by Wimley et al. (1998)
when studying the partition of an hydrophobic peptide into
LUV.
The calculation of the mean occupation number of
a liposome by antibiotic molecules, hAi, is affected by the
partition coefﬁcient chosen to compute its value, either the
experimental coefﬁcient or the apparent one, Kp or Kapp ,
respectively (Fig. 8 C). As expected, the more extensive the
nystatin oligomerization is, the more divergent are the two
computed values. For example, in Fig. 8 C the relative
deviation between the hAi values reaches ;23% and 45%
for 10 and14 mM nystatin, respectively. The correct pro-
cedure is of course to use Kapp in Eq. 9. However, it should be
noted that without having independent knowledge about
the aggregation number and the association constant of the
antibiotic in the lipid vesicles beforehand, it is neither
possible to estimate the mole fraction of antibiotic molecules
involved in aggregate formation, xAgl , nor to determine K
ap
p .
The use of the partition coefﬁcient, Kp, in every calculation
is thus equivalent to admit that nystatin self-association is not
signiﬁcant in any of the experimental conditions used, which
may not always be true. Despite this problem, it is important
to realize that the experimental determination of hAi* is
never affected by the above approximation. In fact, until
reaching this critical antibiotic concentration, Kp is essen-
tially equal to Kapp , as shown in Fig. 8 B. In addition, the
performance of other simulations (using different total lipid
and antibiotic concentrations) also revealed that the use of
this approximation in the computation of hAi did not prevent
the description of all the data by a universal curve of hticalc
versus hAi (see next section). These simulations showed that
the scattering of hticalc versus hAi was similar to the one
found experimentally for hti versus hAi.
The second important question raised by the model
presented above is whether it can reproduce or not, even if
only in a qualitative fashion, the abrupt increment registered
by nystatin mean ﬂuorescence lifetime upon increasing the
occupation number of the liposomes by the antibiotic. The
testing of this condition requires the assumption of some
additional approximations in order for the theoretical
calculation of the mean ﬂuorescence lifetime of nystatin to
be possible from the mole fractions of antibiotic computed
for each sample. In this respect, it was considered that 1), the
radiative rate constant and the molar absorption coefﬁcient of
nystatin were both independent of its location (either
aqueous solution or membrane-bound) and aggregation state
(monomer or oligomer); and 2), that the absorbance of nys-
tatin samples was always low. In fact, the tetrane oscilla-
tor strength is largely insensitive to the dielectric properties
of its environment and this chromophore does not present
signiﬁcant solvatochromatic effects (Coutinho and Prieto,
1995). The decay law of a nystatin sample, Imix(t), should
then be equal to:
ImixðtÞ ¼ xMw IMw ðtÞ1 xMl IMl ðtÞ1 xAgl IAgl ðtÞ: (21)
IMw ðtÞ and IMl ðtÞ represent the intrinsic ﬂuorescence decay
curves of monomeric nystatin in the aqueous phase and
membrane-bound, respectively, and IAgl ðtÞ is the ﬂuores-
cence emission decay kinetics of nystatin included in an
oligomer. As previously mentioned, although the phospho-
lipid concentrations used in the experiments carried out with
gel-phase SUV (1\ [L]t\ 3 mM) implied that there was
always a signiﬁcant fraction of antibiotic molecules in the
aqueous solution (0.50 – 0.59[ xMw [ 0.25 – 0.32), their
contribution to the ﬂuorescence intensity decay curve of each
sample may be ignored because they have only a very fast
decay component (Petersen et al., 1987). In this way, the
previous equation reduces to:
ImixðtÞ ¼ xMl IMl ðtÞ1 xAgl IAgl ðtÞ: (22)
According to the experimental data, it was admitted that
both the membrane-bound nystatin monomers and oligomers
had complex ﬂuorescence emission decay curves described
by a three-exponential sum:
IMl ðtÞ ¼ +
3
i¼1
aMi expðt=tMiÞ; (23)
IAgl ðtÞ ¼ +
3
i¼1
aAgi expðt=tAgiÞ; (24)
with
+
3
i¼1
aMi ¼ 1 and +
3
i¼1
aAgi ¼ 1: (25 and 26)
In this regard, it should be noted that all the ﬂuorescence
decay curves obtained for nystatin were analyzed by em-
pirically ﬁtting a sum of three and not six exponentials to
the experimental data. This simpliﬁcation results from the
impossibility to recover too many meaningful parameters
from the analysis of a single decay curve.
From the previous Eqs. 4, 6, 23, and 24, the following
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expression is derived for the theoretical mean ﬂuorescence
lifetime presented by a nystatin sample:
hticalc ¼
xMl t
M
l
xMl t
M
l 1 x
Ag
l t
Ag
l
htiMl 1
xAgl t
Ag
l
xMl t
M
l 1 x
Ag
l t
Ag
l
htiAgl ; (27)
where til and htiil are the lifetime-weighted quantum yield
and intensity-weighted mean ﬂuorescence lifetimes, re-
spectively, of monomeric (i ¼ M) and oligomeric (i ¼ Ag)
nystatin. This equation shows that hticalc is not a simple
average of htiMl and htiAgl weighted by the antibiotic mole
fractions since til , which is proportional to the species
ﬂuorescence quantum yield, also appears in the weighting
factors. Therefore, if the ﬂuorescence quantum yield of nys-
tatin aggregates is much larger than the one characteristic
of the monomeric antibiotic molecules, the relative contrib-
ution of htiAgl for hticalc may be signiﬁcant even if very few
antibiotic molecules are self-assembled in the lipid bilayer,
and hticalc rapidly reaches its limiting value htiAgl . This
general conclusion is exempliﬁed in Fig. 8 C. The am-
plitudes and decay times chosen for monomeric (aM1 ¼
0.63; aM2 ¼ 0.36; aM3 ¼ 0.01; tM1 ¼ 2.6 ns; tM2 ¼ 8.1 ns
and tM3 ¼ 28 ns;htiMl ¼ 7.4 ns) and aggregated nystatin
(aAg1¼ 0.40; aAg2¼ 0.10; aAg3¼ 0.50; tAg1¼ 2.4 ns; tAg2
¼ 14.0 ns; and tAg3 ¼ 42 ns; htiAgl ¼ 38.7 ns) were based
upon the limiting values experimentally found for very
diluted and concentrated nystatin samples (hAi  10 and
hAi 10, respectively). This choice implied that tAgl  5tMl
and therefore, in the simulation conditions used in Fig. 8 C,
the participation of only 30% of the antibiotic molecules
in hexamer formation was sufﬁcient for hticalc to reach
asymptotically htiAgl ¼ 38.7 ns.
Eq. 27 also shows indirectly that for each model
membrane system used, the variation of hticalc between its
limiting values, htiMl and htiAgl , is essentially conditioned by
the choice made for z and Kag, the parameters that describe
the antibiotic oligomerization process within the lipid bi-
layer. As in any other co-operative process, the larger the
z value is, the more abrupt the transition of hticalc between its
limiting values is expected to be. Therefore, and within all
the constraints discussed above, the model proposed for
nystatin interaction with the lipid vesicles can be ﬁtted to the
experimental data of hti versus hAi through ﬁnding a pair of
values for z and Kag that simultaneously minimize the root-
mean-square (RMS) deviations between the experimental
and calculated values for the intensity-weighted mean ﬂuo-
rescence lifetime of nystatin, htiexp and hticalc, respectively:
RMS ¼ +
n
i¼1
ðhtii;exp  htii;calcÞ2=ðn 1Þ
 1=2
; (28)
where n is the number of data points used in each ﬁtting
procedure. Because of the high correlation between z and
Kag, z (integer) was ﬁxed and Kag (or K9ag) was varied in each
RMS minimization. Table 5 and Fig. 4 C show that nystatin
reversibly assembles into aggregates of 6 6 2 antibiotic
molecules when interacting with gel-phase DPPC SUV.
Comparison with the literature
The above model proposed for nystatin interaction with the
phospholipid vesicles is also supported by several spectro-
scopic and calorimetric studies carried out mainly with
AmB. From the experimental data obtained using CD and
differential scanning calorimetry (DSC), it was proposed that
AmB underwent an oligomerization process in the lipid
bilayer as well (Bolard et al., 1980; Vertut-Croquin et al.,
1983; Balakrishnan and Easwaran, 1993; Fournier et al.,
1998). For example, using SUV prepared from egg-yolk
lecithin, Vertut-Croquin et al. (1983) found that the CD
spectrum of AmB was typical of a monomer adsorbed at
the lipid bilayer interface only when very low antibiotic-to-
phospholipid ratios, RA:L, were used. Upon increasing RA:L,
the CD spectrum of the samples progressively changed
showing some new characteristics, which were ascribed
to the insertion of the antibiotic molecules in a more rigid
environment. Later, using DPPC SUV in the ﬂuid phase,
Balakrishnan and Easwaran (1993) showed unequivocally
that the changes detected in the CD spectra of AmB upon
varying the antibiotic-to-phospholipid molar ratio used were
due to an aggregation process of the antibiotic in the lipid
bilayer.
On the other hand, Grant et al. (1989) and Hamilton et al.
(1991) determined partial phase diagrams for AmB in-
corporated in liposomes with a variable lipid composition
(prepared with saturated or unsaturated phospholipids) using
TABLE 5 Determination of nystatin aggregation number, z, in gel-phase DPPC vesicles
z*
3 4 5 6 7 8 9 10 11 12
K9ag* (mmol)
1z 9.6 3 103 3.0 3 103 1.0 3 103 3.7 3 104 1.4 3 104 5.3 3 105 2.0 3 105 8.0 3 106 3.1 3 106 1.2 3 106
RMS 5.36 4.70 4.48 4.44 4.48 4.56 4.65 4.74 4.83 4.91
The cooperative partition model of nystatin in interaction with the lipid vesicles was ﬁtted to the experimental data of hti versus hAi (n ¼ 86) according to the
procedure described in the text. K9ag was allowed to vary in each minimization of the root-mean-square deviations (RMSD), while z was kept constant at
different integer numbers. These results are presented in the inset of Fig. 4.
*Kag can be obtained from Eq. 11.
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electron spin resonance and DSC, respectively. Regarding
nystatin, Milhaud et al. (1997) also obtained a partial phase
diagram for this antibiotic incorporated in dilauroylphos-
phatidylcholine liposomes by carrying out DSC measure-
ments. All the partial phase diagrams obtained, except for the
dimyristoylphosphatidylcholine: dimyristoylphosphatidyl-
glycerol (DMPC:DMPG) 7:3 system employed, suggested
that within the antibiotic concentration ranges used (0–17 or
33 mol% of antibiotic) there was an immiscibility of com-
ponents in the solid phase since the solidus line was approxi-
mately horizontal. Hence, the antibiotic molecules were not
uniformly distributed in the solid matrix of phospholipid;
rather they segregated and formed a distinct phase. This seg-
regation may be explained by the distinct structural character-
istics of the polyene antibiotics compared to the surrounding
phospholipids. On the other hand, the liquidus line showed a
positive slope because the temperature corresponding to the
ending of the phospholipid phase transition increasedwith the
antibiotic content of the lipid vesicles. This result suggests
that antibiotic-enriched domains are formed in the lipid bi-
layers which have a higher transition temperature compared
with the one obtained with pure phospholipids. This effect
was conﬁrmed for nystatin and ﬁlipin (Bolard and Milhaud,
1996), as well as for AmB (Fournier et al., 1998).
It should be noted that there is no apparent contradiction
between these studies and the model developed here for
nystatin, although the last one admits that membrane-bound
antibiotic molecules self-associate into aggregates with
a well-deﬁned stoichiometry. In fact, due to the distinct sen-
sitivity of the techniques employed in each study (electron
spin resonance, deuterium nuclear magnetic resonance
(2H-NMR), and DSC compared to ﬂuorescence), the phos-
pholipid-to-antibiotic ratios used were very different. There-
fore, it is possible that upon increasing the antibiotic mole
fraction in the liposomes, there is an increased formation
ofaggregates thatmayprogressivelycoalesce, ultimately lead-
ing to a phase separation, as it is observed in the DSC studies.
The phase separation may be complete when the lipid vesi-
cles are in a gel phase or only partial, when the liposomes are
kept in a ﬂuid phase.
Finally, 2H-NMR studies carried out with 30 mol% of
AmB (Dufourc et al, 1984) or ;5 and 33 mol% nystatin
(Milhaud et al., 1997) demonstrated the ability of these
polyene antibiotics in rigidifying their lipid microenviron-
ment. The ﬁrst study suggested that AmB was able to induce
an all-trans conformation in the acyl chains of the
phospholipids. On the other hand, the 2H-NMR experiments
carried out with nystatin showed that this antibiotic increased
the lipid order only at temperatures immediately above Tm,
causing an increase in the phospholipid bilayer width of
;0.2 nm. In addition, nystatin produced an increased order
of all deuterated positions of an acyl chain, with this effect
being more pronounced in the center of the lipid bilayer.
CONCLUSIONS
The sensitivity of the ﬂuorescence emission properties of
nystatin to the characteristics of its microenvironment was
explored here to study its interaction with liposomes of
different phospholipid composition, phase, and curvature
radius. The main conclusions obtained were:
1. The larger partition coefﬁcient found for nystatin toward
gel-phase DPPC SUV compared to DPPC LUV was
ascribed to the presence of a large number of interfacial
packing defects in the smaller vesicles, which must
facilitate nystatin incorporation. For the liposomes kept in
a ﬂuid phase (SUVorLUVpreparedwithDPPCor POPC),
and for gel-phase DPPC LUV, an antibiotic partition
coefﬁcient of (1.36 0.3)3 104 was always obtained.
2. The ﬂuorescence emission decay kinetics of nystatin in
DPPC SUV and LUV in the gel phase was found to be
controlled by the mean number of membrane bound
antibiotic molecules per lipid vesicle, hAi. Above
a critical concentration, hAi*  10, there was a pro-
nounced increase in the antibiotic mean ﬂuorescence
lifetime from 7–10 to ;35 ns. This change in the decay
kinetics of nystatin was attributed to interactions between
the antibiotic molecules that drove its oligomerization in
the lipid vesicles. Since the antibiotic molecules in the
aggregates formed experienced a more rigid environ-
ment, there was a decrease in its nonradiative rate con-
stant which produced the reported variation in nystatin
mean ﬂuorescence lifetime.
3. The depth-dependent quenching studies carried out with
the spin-labeled fatty acids (5- and 16-doxyl stearic
acids) showed that monomeric nystatin was anchored at
the phospholipid/water interface, and suggested that
nystatin assembly into aggregates was followed by their
translocation into the membrane.
4. Altogether, these results could be adequately explained
by a mathematical model which assumes that monomeric
nystatin molecules partition into the lipid bilayer and
reversibly aggregate to form channels consisting of 66 2
antibiotic molecules. Furthermore, our data shows that the
utilization of membrane-containing sterols is not an es-
sential condition for nystatin to assemble into aggregates.
The inﬂuence that more biologically relevant lipid mixtures,
namely ergosterol- and cholesterol-containing lipid bilayers,
have on nystatin oligomerization, will be presented in a future
work.
This study was supported by project POCTI/36389/FCB/2000 (Fundac¸a˜o
para a Cieˆncia e Tecnologia, Portugal).
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